Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Engelhardt

Showing results (131-140 of 227) with videos related to

Pageof 23
Sort By:
BMC Cancer|February 18, 2021
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measuresMonika Engelhardt, Gabriele Ihorst, Martin Schumacher, et al.
Leukemia & Lymphoma|February 17, 2012
Aggressive plasmablastic lymphoproliferation complicated by hemophagocytic syndrome 12 years after heart transplantAnna-Kristina Reuland, Monika Engelhardt, Philipp T Meyer, et al.
Korean Journal of Radiology|September 19, 2023
Impact of Photon-Counting Detector Computed Tomography on Image Quality and Radiation Dose in Patients With Multiple MyelomaAlexander Rau, Jakob Neubauer, Laetitia Taleb, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 8, 2025
A Randomized Controlled 'REAL-FITNESS' Trial to Evaluate Physical Activity in Patients With Newly Diagnosed Multiple MyelomaEsther Dreyling, Jan Räder, Mandy-Deborah Möller, et al.
British Journal of Haematology|November 20, 2002
Telomere maintenance in human B lymphocytesUwe M Martens, Volker Brass, Lucie Sedlacek, et al.
Leukemia & Lymphoma|November 23, 2020
Interdisciplinary approach to multiple myeloma - time to diagnosis and warning signsGeorg W Herget, Felix Kälberer, Gabriele Ihorst, et al.
Haematologica|November 3, 2022
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherenceMaximilian Holler, Gabriele Ihorst, Heike Reinhardt, et al.
Annals of Hematology|March 13, 2021
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumabKhalid Shoumariyeh, Johannes Jung, Michael Rassner, et al.
Haematologica|October 16, 2025
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centersPeter May, Michael Rassner, Marion Hoegner, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Pageof 23

Showing results (131-140 of 227) with videos related to

Sort By:
Pageof 23
BMC Cancer|February 18, 2021
Multidisciplinary tumor boards and their analyses: the yin and yang of outcome measuresMonika Engelhardt, Gabriele Ihorst, Martin Schumacher, et al.
Leukemia & Lymphoma|February 17, 2012
Aggressive plasmablastic lymphoproliferation complicated by hemophagocytic syndrome 12 years after heart transplantAnna-Kristina Reuland, Monika Engelhardt, Philipp T Meyer, et al.
Korean Journal of Radiology|September 19, 2023
Impact of Photon-Counting Detector Computed Tomography on Image Quality and Radiation Dose in Patients With Multiple MyelomaAlexander Rau, Jakob Neubauer, Laetitia Taleb, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 8, 2025
A Randomized Controlled 'REAL-FITNESS' Trial to Evaluate Physical Activity in Patients With Newly Diagnosed Multiple MyelomaEsther Dreyling, Jan Räder, Mandy-Deborah Möller, et al.
British Journal of Haematology|November 20, 2002
Telomere maintenance in human B lymphocytesUwe M Martens, Volker Brass, Lucie Sedlacek, et al.
Leukemia & Lymphoma|November 23, 2020
Interdisciplinary approach to multiple myeloma - time to diagnosis and warning signsGeorg W Herget, Felix Kälberer, Gabriele Ihorst, et al.
Haematologica|November 3, 2022
An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherenceMaximilian Holler, Gabriele Ihorst, Heike Reinhardt, et al.
Annals of Hematology|March 13, 2021
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumabKhalid Shoumariyeh, Johannes Jung, Michael Rassner, et al.
Haematologica|October 16, 2025
Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centersPeter May, Michael Rassner, Marion Hoegner, et al.
Frontiers in Oncology|September 6, 2021
Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma PatientsVeronika Riebl, Sandra Maria Dold, Dagmar Wider, et al.
Pageof 23